Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Improvement in Endoscopic Mucosal Visibility Using a Pre-procedure Combination Drink of N-acetylcysteine and Simethicone
NCT05801055Phase 3Unknown
- Sponsor
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
- Start
- Apr 2023
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of acetylcysteine and simethicone (2 arms), sponsored by Sanjay Gandhi Postgraduate Institute of Medical Sciences. Primary endpoint: Adequate Gastric Mucosal Visibility up to 3 months. Status: unknown.
02
Drugs
acetylcysteinesimethicone
Beyond the preview
Go deeper on NCT05801055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05801055.